SCOPUS 정보 검색 플랫폼

Journal of Clinical Pharmacology

Volumn 39, Issue 8, 1999, Pages 800-804

Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects

(2) Jung, D a Dorr, A a

a NONE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VALGANCICLOVIR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOMEGALOVIRUS INFECTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 0033325221 PISSN: 00912700 EISSN: None Source Type: Journal
DOI: 10.1177/00912709922008452 Document Type: Article

Times cited : (146)

References (6)

1
- 0008425509
- Cytomegalovirus infection in patients with AIDS
- (1992) Clin Infect Dis , vol.6 , pp. 194-196
- Drew, W.L.¹

2
- 0029143294
- Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS
- for the Syntex Cooperative Oral Ganciclovir Study Group
- (1995) N Engl J Med , vol.333 , pp. 615-620
- Drew, W.L.¹ Ives, D.² Lalezari, J.P.³ Crumpacker, C.⁴ Follansbee, S.E.⁵ Specter, S.A.⁶ Benson, C.A.⁷ Friederg, D.N.⁸ Hubbard, L.⁹ Stempien, M.J.¹⁰ Shadman, A.¹¹ Buhles, W.¹²

3
- 0029027137
- Pharmacokinetic, safety and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: A phase I/II study
- AIDS Clinical Trials Group, Cytomegalovirus Cooperative Study Group
- (1995) J Infect Dis , vol.171 , pp. 1431-1437
- Specter, S.A.¹ Busch, D.E.² Follansbee, S.³ Squires, K.⁴ Lalezari, J.P.⁵ Jacobson, M.A.⁶ Jung, D.⁷ Shadman, A.⁸ Mastre, B.⁹ Buhles, W.¹⁰ Drew, W.L.¹¹

4
- 0023627691
- Human pharmacokinetics and tolerance of oral ganciclovir
- (1987) Antimicrob Agents Chemother , vol.31 , pp. 1251-1254
- Jacobson, M.A.¹ DeMiranda, P.² Cederberg, D.M.³ Burnette, T.⁴ Cobb, E.⁵ Brody, H.R.⁶ Mills, J.⁷

5
- 0029151391
- Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/day dosing regimens in human immunodeficiency virus- and cytomegalovirus-seropostitive patients
- (1995) Clin Ther , vol.17 , pp. 425-432
- Anderson, R.¹ Griffy, K.G.² Jung, D.³ Dorr, A.⁴ Hulse, J.D.⁵ Smith, R.B.⁶

6
- 0032936463
- Effect of food on high-dose oral ganciclovir disposition in HIV-positive subiects
- (1999) J Clin Pharmacol , vol.39 , pp. 1-5
- Jung, D.¹ Griffy, K.² Dorr, A.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.